allergan plc

Allergan PLC sees a massive surge in social mentions and creator activity, up 200% and 175% respectively. Engagements are also up 21% week-over-week, indicating heightened public interest.

About allergan plc

Allergan Plc is a pharmaceutical company known for its medical aesthetics products.

Insights

allergan plc mentions hit [--] which is 200% higher than it's daily average.
allergan plc creators hit [--] which is 175% higher than it's daily average.
allergan plc creators is up 30% from the previous month.
allergan plc engagements is up 21.23% from the previous week.

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [-----] +21%
[--] Month: [-----] -28%
[--] Months: [------] +1,167%
[--] Year: [------] +137%
1-Year High: [------] on 2025-09-26
1-Year Low: [--] on 2025-02-25

Engagements by network (24h): Reddit: [---] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +7.10%
[--] Month: [--] +14%
[--] Months: [--] +365%
[--] Year: [--] +75%
1-Year High: [--] on 2025-09-26
1-Year Low: [--] on 2025-02-18

Mentions by network (24h): Reddit: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning allergan plc in the last [--] hours which is up 22% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +20%
[--] Month: [--] +30%
[--] Months: [--] +308%
[--] Year: [--] +90%
1-Year High: [--] on 2025-09-26
1-Year Low: [--] on 2025-02-18

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 90%
[--] Week: 83% +3%
[--] Month: 90% no change
[--] Months: 90% +70%
[--] Year: 90% -10%
1-Year High: 100% on 2025-03-24
1-Year Low: 20% on 2025-04-23

Most Supportive Themes:

Merger with Pfizer: (50%) Discussions around the potential merger between Allergan Plc and Pfizer Inc. were a significant topic, with various political figures and news outlets commenting on its implications, particularly concerning tax benefits and regulatory scrutiny.
Drug Pricing and Policy: (30%) The context highlights discussions on drug price increases by Pfizer and the broader political response to corporate inversions and tax avoidance strategies, with Allergan Plc being a central element in these conversations.

Most Critical Themes:

Regulatory Scrutiny and Political Opposition: (20%) The proposed merger faced significant political opposition, with figures like Bernie Sanders urging the Obama administration to block the deal due to concerns about tax-avoiding corporate inversions. This indicates a critical stance from certain political factions.

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing